Article
Induction gemcitabine-based chemotherapy and neoadjuvant stereotactic body radiation therapy achieve high margin-negative resection rates for borderline resectable pancreatic cancer
Journal of Radiation Oncology
(2012)
Disciplines
Publication Date
2012
Citation Information
Michael Chuong and Springett GM, Weber JM, Klapman J, Vignesh S, Hodul PJ, Malafa MP, Leuthold S, Hoffe SE, Shridhar R. "Induction gemcitabine-based chemotherapy and neoadjuvant stereotactic body radiation therapy achieve high margin-negative resection rates for borderline resectable pancreatic cancer" Journal of Radiation Oncology Vol. 1 Iss. 3 (2012) p. 273 - 281 Available at: http://works.bepress.com/michael-chuong/66/